The clinic discussed peptides alongside non-invasive and surgical rejuvenation procedures before the VASTOZ conference this November.
Recap by typeshit. Post by @shaferclinic on Instagram.
A short link post on what patients should keep in mind as options for semaglutide and tirzepatide keep shifting. Details are at the source.
A short clip from obesity doctor Nadolsky with his three pointers for people about to begin GLP-1 treatment. The details are in the video.
A general explainer on how GLP-1 receptor agonists affect blood sugar and appetite, with advice on support while taking them.
A sponsored-style look at compounded tirzepatide and semaglutide through telehealth firm Mochi Health, noting compounded drugs aren't FDA approved for safety or quality.
He points to preliminary signs that the drugs may curb cravings for addictive substances, but says stronger data should come before wider access.
Medscape reports national prescription data showing the pill reached that mark within two months of its January 2026 launch, with faster early uptake than injectable tirzepatide or semaglutide.
Loading…